<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 20 Aug 2026 20:05:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  4          Viridian Therapeutics,    For: Aug 19  Filed by: Tousignant Jennifer</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Viridian+Therapeutics%2C++++For%3A+Aug+19++Filed+by%3A+Tousignant+Jennifer/26957513.html</link>
   <description>si-local-file:///var/storage/secattach/20260820/26957513.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Viridian+Therapeutics%2C++++For%3A+Aug+19++Filed+by%3A+Tousignant+Jennifer/26957513.html</guid>
   <pubDate>Thu, 20 Aug 2026 20:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.13483677</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>Form  4          Viridian Therapeutics,    For: Aug 19  Filed by: Tousignant Jennifer</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Viridian+Therapeutics%2C++++For%3A+Aug+19++Filed+by%3A+Tousignant+Jennifer/26957513.html</link>
   <description>si-local-file:///var/storage/secattach/20260820/26957513.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Viridian+Therapeutics%2C++++For%3A+Aug+19++Filed+by%3A+Tousignant+Jennifer/26957513.html</guid>
   <pubDate>Thu, 20 Aug 2026 20:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.13483677</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G  Viridian Therapeutics,                 Filed by: Point72 Asset Management, L.P.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Viridian+Therapeutics%2C+++++++++++++++++Filed+by%3A+Point72+Asset+Management%2C+L.P./26956355.html</link>
   <description>si-local-file:///var/storage/secattach/20260820/26956355.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Viridian+Therapeutics%2C+++++++++++++++++Filed+by%3A+Point72+Asset+Management%2C+L.P./26956355.html</guid>
   <pubDate>Thu, 20 Aug 2026 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.13483677</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G  Viridian Therapeutics,                 Filed by: Point72 Asset Management, L.P.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Viridian+Therapeutics%2C+++++++++++++++++Filed+by%3A+Point72+Asset+Management%2C+L.P./26956355.html</link>
   <description>si-local-file:///var/storage/secattach/20260820/26956355.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Viridian+Therapeutics%2C+++++++++++++++++Filed+by%3A+Point72+Asset+Management%2C+L.P./26956355.html</guid>
   <pubDate>Thu, 20 Aug 2026 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.13483677</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>Form  144        Viridian Therapeutics,                 Filed by: Tousignant Jennifer</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Viridian+Therapeutics%2C+++++++++++++++++Filed+by%3A+Tousignant+Jennifer/26949531.html</link>
   <description>si-local-file:///var/storage/secattach/20260819/26949531.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Viridian+Therapeutics%2C+++++++++++++++++Filed+by%3A+Tousignant+Jennifer/26949531.html</guid>
   <pubDate>Wed, 19 Aug 2026 14:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.13483677</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>Form  144        Viridian Therapeutics,                 Filed by: Tousignant Jennifer</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Viridian+Therapeutics%2C+++++++++++++++++Filed+by%3A+Tousignant+Jennifer/26949531.html</link>
   <description>si-local-file:///var/storage/secattach/20260819/26949531.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Viridian+Therapeutics%2C+++++++++++++++++Filed+by%3A+Tousignant+Jennifer/26949531.html</guid>
   <pubDate>Wed, 19 Aug 2026 14:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.13483677</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>Form  4          Viridian Therapeutics,    For: Aug 14  Filed by: Tripuraneni Radhika</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Viridian+Therapeutics%2C++++For%3A+Aug+14++Filed+by%3A+Tripuraneni+Radhika/26945608.html</link>
   <description>si-local-file:///var/storage/secattach/20260818/26945608.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Viridian+Therapeutics%2C++++For%3A+Aug+14++Filed+by%3A+Tripuraneni+Radhika/26945608.html</guid>
   <pubDate>Tue, 18 Aug 2026 17:34:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.13483677</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>Form  4          Viridian Therapeutics,    For: Aug 14  Filed by: Tripuraneni Radhika</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Viridian+Therapeutics%2C++++For%3A+Aug+14++Filed+by%3A+Tripuraneni+Radhika/26945608.html</link>
   <description>si-local-file:///var/storage/secattach/20260818/26945608.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Viridian+Therapeutics%2C++++For%3A+Aug+14++Filed+by%3A+Tripuraneni+Radhika/26945608.html</guid>
   <pubDate>Tue, 18 Aug 2026 17:34:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.13483677</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  Viridian Therapeutics,                 Filed by: Paradigm Biocapital Advisors LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Viridian+Therapeutics%2C+++++++++++++++++Filed+by%3A+Paradigm+Biocapital+Advisors+LP/26931441.html</link>
   <description>si-local-file:///var/storage/secattach/20260814/26931441.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Viridian+Therapeutics%2C+++++++++++++++++Filed+by%3A+Paradigm+Biocapital+Advisors+LP/26931441.html</guid>
   <pubDate>Fri, 14 Aug 2026 16:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.13483677</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  Viridian Therapeutics,                 Filed by: Paradigm Biocapital Advisors LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Viridian+Therapeutics%2C+++++++++++++++++Filed+by%3A+Paradigm+Biocapital+Advisors+LP/26931441.html</link>
   <description>si-local-file:///var/storage/secattach/20260814/26931441.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Viridian+Therapeutics%2C+++++++++++++++++Filed+by%3A+Paradigm+Biocapital+Advisors+LP/26931441.html</guid>
   <pubDate>Fri, 14 Aug 2026 16:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.13483677</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  Viridian Therapeutics,                 Filed by: Kynam Capital Management, LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Viridian+Therapeutics%2C+++++++++++++++++Filed+by%3A+Kynam+Capital+Management%2C+LP/26927758.html</link>
   <description>si-local-file:///var/storage/secattach/20260814/26927758.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Viridian+Therapeutics%2C+++++++++++++++++Filed+by%3A+Kynam+Capital+Management%2C+LP/26927758.html</guid>
   <pubDate>Fri, 14 Aug 2026 12:18:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.13483677</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  Viridian Therapeutics,                 Filed by: Kynam Capital Management, LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Viridian+Therapeutics%2C+++++++++++++++++Filed+by%3A+Kynam+Capital+Management%2C+LP/26927758.html</link>
   <description>si-local-file:///var/storage/secattach/20260814/26927758.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Viridian+Therapeutics%2C+++++++++++++++++Filed+by%3A+Kynam+Capital+Management%2C+LP/26927758.html</guid>
   <pubDate>Fri, 14 Aug 2026 12:18:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.13483677</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G  Viridian Therapeutics,                 Filed by: PRICE T ROWE ASSOCIATES INC /MD/</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Viridian+Therapeutics%2C+++++++++++++++++Filed+by%3A+PRICE+T+ROWE+ASSOCIATES+INC+MD/26926646.html</link>
   <description>si-local-file:///var/storage/secattach/20260814/26926646.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Viridian+Therapeutics%2C+++++++++++++++++Filed+by%3A+PRICE+T+ROWE+ASSOCIATES+INC+MD/26926646.html</guid>
   <pubDate>Fri, 14 Aug 2026 10:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.13483677</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G  Viridian Therapeutics,                 Filed by: PRICE T ROWE ASSOCIATES INC /MD/</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Viridian+Therapeutics%2C+++++++++++++++++Filed+by%3A+PRICE+T+ROWE+ASSOCIATES+INC+MD/26926646.html</link>
   <description>si-local-file:///var/storage/secattach/20260814/26926646.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Viridian+Therapeutics%2C+++++++++++++++++Filed+by%3A+PRICE+T+ROWE+ASSOCIATES+INC+MD/26926646.html</guid>
   <pubDate>Fri, 14 Aug 2026 10:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.13483677</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  Viridian Therapeutics,                 Filed by: Deep Track Capital, LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Viridian+Therapeutics%2C+++++++++++++++++Filed+by%3A+Deep+Track+Capital%2C+LP/26925193.html</link>
   <description>si-local-file:///var/storage/secattach/20260814/26925193.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Viridian+Therapeutics%2C+++++++++++++++++Filed+by%3A+Deep+Track+Capital%2C+LP/26925193.html</guid>
   <pubDate>Fri, 14 Aug 2026 08:33:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.13483677</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  Viridian Therapeutics,                 Filed by: Deep Track Capital, LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Viridian+Therapeutics%2C+++++++++++++++++Filed+by%3A+Deep+Track+Capital%2C+LP/26925193.html</link>
   <description>si-local-file:///var/storage/secattach/20260814/26925193.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Viridian+Therapeutics%2C+++++++++++++++++Filed+by%3A+Deep+Track+Capital%2C+LP/26925193.html</guid>
   <pubDate>Fri, 14 Aug 2026 08:33:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.13483677</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G  Viridian Therapeutics,                 Filed by: STATE STREET CORP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Viridian+Therapeutics%2C+++++++++++++++++Filed+by%3A+STATE+STREET+CORP/26889345.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26889345.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Viridian+Therapeutics%2C+++++++++++++++++Filed+by%3A+STATE+STREET+CORP/26889345.html</guid>
   <pubDate>Fri, 07 Aug 2026 11:13:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.13483677</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G  Viridian Therapeutics,                 Filed by: STATE STREET CORP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Viridian+Therapeutics%2C+++++++++++++++++Filed+by%3A+STATE+STREET+CORP/26889345.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26889345.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Viridian+Therapeutics%2C+++++++++++++++++Filed+by%3A+STATE+STREET+CORP/26889345.html</guid>
   <pubDate>Fri, 07 Aug 2026 11:13:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.13483677</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>Viridian Reports Continuation of Massive Sulphides at Kraken Main; First Assays Pending</title>
   <link>http://www.streetinsider.com/Press+Releases/Viridian+Reports+Continuation+of+Massive+Sulphides+at+Kraken+Main%3B+First+Assays+Pending/26882917.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;OTTAWA, Ontario, Aug.  06, 2026  (GLOBE NEWSWIRE) -- Assays are now pending from the first diamond drill holes completed as part of Viridian Metals Inc.&amp;apos;s (CSE: VRDN) (OTCQB: VIRMF) 2026 drill program at the Kraken project in Labrador. The initial assay submission includes the extension of hole VKS25-024, which previously returned 24.05 metres grading 0.77% CuEq¹ (0.21% Cu, 0.30% Ni, 0.04% Co) from 1 metre before terminating in mineralization (see Viridian news release dated February 26, 2025). Massive to semi-massive sulphides observed at the end of the original hole continue to approximately 33 metres, transitioning to patchy</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Viridian+Reports+Continuation+of+Massive+Sulphides+at+Kraken+Main%3B+First+Assays+Pending/26882917.html</guid>
   <pubDate>Thu, 06 Aug 2026 15:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CCPC.P</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53771462</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VIRMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>Viridian Reports Continuation of Massive Sulphides at Kraken Main; First Assays Pending</title>
   <link>http://www.streetinsider.com/Press+Releases/Viridian+Reports+Continuation+of+Massive+Sulphides+at+Kraken+Main%3B+First+Assays+Pending/26882917.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;OTTAWA, Ontario, Aug.  06, 2026  (GLOBE NEWSWIRE) -- Assays are now pending from the first diamond drill holes completed as part of Viridian Metals Inc.&amp;apos;s (CSE: VRDN) (OTCQB: VIRMF) 2026 drill program at the Kraken project in Labrador. The initial assay submission includes the extension of hole VKS25-024, which previously returned 24.05 metres grading 0.77% CuEq¹ (0.21% Cu, 0.30% Ni, 0.04% Co) from 1 metre before terminating in mineralization (see Viridian news release dated February 26, 2025). Massive to semi-massive sulphides observed at the end of the original hole continue to approximately 33 metres, transitioning to patchy</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Viridian+Reports+Continuation+of+Massive+Sulphides+at+Kraken+Main%3B+First+Assays+Pending/26882917.html</guid>
   <pubDate>Thu, 06 Aug 2026 15:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CCPC.P</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53771462</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VIRMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>Viridian Reports Continuation of Massive Sulphides at Kraken Main; First Assays Pending</title>
   <link>http://www.streetinsider.com/Press+Releases/Viridian+Reports+Continuation+of+Massive+Sulphides+at+Kraken+Main%3B+First+Assays+Pending/26882917.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;OTTAWA, Ontario, Aug.  06, 2026  (GLOBE NEWSWIRE) -- Assays are now pending from the first diamond drill holes completed as part of Viridian Metals Inc.&amp;apos;s (CSE: VRDN) (OTCQB: VIRMF) 2026 drill program at the Kraken project in Labrador. The initial assay submission includes the extension of hole VKS25-024, which previously returned 24.05 metres grading 0.77% CuEq¹ (0.21% Cu, 0.30% Ni, 0.04% Co) from 1 metre before terminating in mineralization (see Viridian news release dated February 26, 2025). Massive to semi-massive sulphides observed at the end of the original hole continue to approximately 33 metres, transitioning to patchy</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Viridian+Reports+Continuation+of+Massive+Sulphides+at+Kraken+Main%3B+First+Assays+Pending/26882917.html</guid>
   <pubDate>Thu, 06 Aug 2026 15:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CCPC.P</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53771462</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VIRMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>Viridian Reports Continuation of Massive Sulphides at Kraken Main; First Assays Pending</title>
   <link>http://www.streetinsider.com/Press+Releases/Viridian+Reports+Continuation+of+Massive+Sulphides+at+Kraken+Main%3B+First+Assays+Pending/26882917.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;OTTAWA, Ontario, Aug.  06, 2026  (GLOBE NEWSWIRE) -- Assays are now pending from the first diamond drill holes completed as part of Viridian Metals Inc.&amp;apos;s (CSE: VRDN) (OTCQB: VIRMF) 2026 drill program at the Kraken project in Labrador. The initial assay submission includes the extension of hole VKS25-024, which previously returned 24.05 metres grading 0.77% CuEq¹ (0.21% Cu, 0.30% Ni, 0.04% Co) from 1 metre before terminating in mineralization (see Viridian news release dated February 26, 2025). Massive to semi-massive sulphides observed at the end of the original hole continue to approximately 33 metres, transitioning to patchy</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Viridian+Reports+Continuation+of+Massive+Sulphides+at+Kraken+Main%3B+First+Assays+Pending/26882917.html</guid>
   <pubDate>Thu, 06 Aug 2026 15:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CCPC.P</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53771462</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VIRMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>Viridian Reports Continuation of Massive Sulphides at Kraken Main; First Assays Pending</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Viridian+Reports+Continuation+of+Massive+Sulphides+at+Kraken+Main%3B+First+Assays+Pending/26882917.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;OTTAWA, Ontario, Aug.  06, 2026  (GLOBE NEWSWIRE) -- Assays are now pending from the first diamond drill holes completed as part of Viridian Metals Inc.&amp;apos;s (CSE: VRDN) (OTCQB: VIRMF) 2026 drill program at the Kraken project in Labrador. The initial assay submission includes the extension of hole VKS25-024, which previously returned 24.05 metres grading 0.77% CuEq¹ (0.21% Cu, 0.30% Ni, 0.04% Co) from 1 metre before terminating in mineralization (see Viridian news release dated February 26, 2025). Massive to semi-massive sulphides observed at the end of the original hole continue to approximately 33 metres, transitioning to patchy</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Viridian+Reports+Continuation+of+Massive+Sulphides+at+Kraken+Main%3B+First+Assays+Pending/26882917.html</guid>
   <pubDate>Thu, 06 Aug 2026 15:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CCPC.P</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53771462</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VIRMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>Viridian Reports Continuation of Massive Sulphides at Kraken Main; First Assays Pending</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Viridian+Reports+Continuation+of+Massive+Sulphides+at+Kraken+Main%3B+First+Assays+Pending/26882917.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;OTTAWA, Ontario, Aug.  06, 2026  (GLOBE NEWSWIRE) -- Assays are now pending from the first diamond drill holes completed as part of Viridian Metals Inc.&amp;apos;s (CSE: VRDN) (OTCQB: VIRMF) 2026 drill program at the Kraken project in Labrador. The initial assay submission includes the extension of hole VKS25-024, which previously returned 24.05 metres grading 0.77% CuEq¹ (0.21% Cu, 0.30% Ni, 0.04% Co) from 1 metre before terminating in mineralization (see Viridian news release dated February 26, 2025). Massive to semi-massive sulphides observed at the end of the original hole continue to approximately 33 metres, transitioning to patchy</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Viridian+Reports+Continuation+of+Massive+Sulphides+at+Kraken+Main%3B+First+Assays+Pending/26882917.html</guid>
   <pubDate>Thu, 06 Aug 2026 15:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CCPC.P</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53771462</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VIRMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>Viridian Reports Continuation of Massive Sulphides at Kraken Main; First Assays Pending</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Viridian+Reports+Continuation+of+Massive+Sulphides+at+Kraken+Main%3B+First+Assays+Pending/26882917.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;OTTAWA, Ontario, Aug.  06, 2026  (GLOBE NEWSWIRE) -- Assays are now pending from the first diamond drill holes completed as part of Viridian Metals Inc.&amp;apos;s (CSE: VRDN) (OTCQB: VIRMF) 2026 drill program at the Kraken project in Labrador. The initial assay submission includes the extension of hole VKS25-024, which previously returned 24.05 metres grading 0.77% CuEq¹ (0.21% Cu, 0.30% Ni, 0.04% Co) from 1 metre before terminating in mineralization (see Viridian news release dated February 26, 2025). Massive to semi-massive sulphides observed at the end of the original hole continue to approximately 33 metres, transitioning to patchy</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Viridian+Reports+Continuation+of+Massive+Sulphides+at+Kraken+Main%3B+First+Assays+Pending/26882917.html</guid>
   <pubDate>Thu, 06 Aug 2026 15:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CCPC.P</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53771462</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VIRMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
 </channel>
</rss>
